VISICU eICU® Patent Reaffirmed … Again

Business Wire, June 15, 2007

U.S. Patent and Trademark Office Reaffirms VISICU's Novel Central Monitoring ICU Process

BALTIMORE -- VISICU Inc., (NASDAQ:EICU), a healthcare information technology and clinical solutions company focused on critical care, confirmed today that the pending reexamination of its patent, filed by iMDSoft, Inc., has concluded successfully with 26 claims being allowed. The VISICU patent describes and claims a system and method for providing continuous, expert network critical care services from a remote location(s).

The United States Patent Office (USPTO) has concluded that the iMDSoft patent does not anticipate any of the claims of the VISICU patent and in fact does not do automated processing of patient data as does the VISICU system. The 26 claims of the VISICU patent have each been differentiated from the many cited references in two separate reexaminations. The USPTO concluded that all of VISICU claims, with clarifying amendments, are allowable over these references. The USPTO's action on the VISICU claims reaffirms VISICU's novel approach of centrally monitoring ICUs and determining when intervention is warranted.

More than 180 hospitals utilize VISICU's eICU([R]) Program featuring high fidelity telemedicine and proprietary early warning and intervention software. VISICU is the first company to receive such U.S. patent protection and the first to bring remote critical care (eICU centers) to the marketplace.

"We are pleased to have the Patent Office again approve the VISICU patent claims and set the record straight in this matter, especially given the negative and misleading publicity put in the marketplace." said Frank Sample, chairman and CEO of VISICU.

The U.S. Patent Office has made notification of this "Notice of Intent" available to the public on its Public Application Information Retrieval (PAIR) website (control number 90008276) which may be accessed through the general web site (www.uspto.gov). A copy of the actual notice will be available on the USPTO website shortly.

About VISICU

VISICU, Inc. (NASDAQ:EICU) is a healthcare information technology and clinical solutions company focused on transforming the delivery of critical care through its eICU([R]) Program. Through remote monitoring technology and clinical intelligence, experienced critical care resources are leveraged to provide coverage and early intervention for safer, more effective patient care. Currently more than 180 hospitals, serving over 250,000 patients annually, have partnered with VISICU to implement eICU programs. More information is available at www.VISICU.com. VISICU([R]) and eICU([R]) are registered trademarks of VISICU, Inc. All rights reserved. All other brand names, product names, company names, trademarks and service marks are the property of their respective owners. visicu-g

Safe Harbor Statement

This release contains forward-looking statements that are made pursuant to the provisions of Section 21E of the Securities and Exchange Act of 1934, as amended. These forward-looking statements involve a number of risks and uncertainties. Investors are cautioned that statements in this release that are not strictly historical statements constitute forward-looking statements. It is important to note that the company's performance, and actual results, financial condition or business could differ materially from those expressed in the forward-looking statements. The words "may", "could", "would", "should", "outlook", "positions us", "guidance", "expects", "estimates", "intends", "plans", "projects", "anticipates", "believes", "predicts", "potential" or the negative of these words, variations thereof or similar expressions are intended to identify such forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could materially affect actual results, levels of activity, performance or achievements. Factors that could cause results to differ materially from current expectations include, but are not limited to: market acceptance of our principal product offering and any new product releases; the price, performance and reliability of our products and services; our ability to attract and retain new customers and renewal rates of our existing customers; unanticipated delays or problems in releasing new products and services; financial and budget constraints of hospitals, changes in our pricing practices or our competitors' pricing practices and changes in the healthcare industry; the introduction or availability of competing products or services and other competitive factors; and changes in the government regulation of our products and services.